Medlive Technology half-year revenue rises 1% on customer base expansion
Medlive Technology half-year revenue rises 1% on customer base expansion
Overview
China medical digital services provider's half-year revenue rose 1% yr/yr
Gross profit and non-HKFRS adjusted net profit both increased modestly yr/yr
Precision marketing and corporate solutions remained main revenue driver
Outlook
Company did not provide specific financial outlook
Result Drivers
PRECISION MARKETING - Precision marketing and corporate solutions remained the main revenue driver, accounting for over 93% of revenue and growing 1.1% yr/yr
CUSTOMER BASE EXPANSION - Number of healthcare customers in precision marketing and corporate solutions rose to 217 from 191 yr/yr
TECHNOLOGICAL ENHANCEMENTS - Co continued to iterate its proprietary medical AI tools and platform, aiming to improve information retrieval and user engagement
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| RMB 315.20 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advertising & marketing peer group is "buy."
Wall Street's median 12-month price target for Medlive Technology Co Ltd is HK$11.40, about 49% above its August 27 closing price of HK$7.65
The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
Aug 27 - Huawei plans for more AI pharma tie-ups, says healthcare president
Aug 28 - China's Tigermed Consulting H1 revenue rises amid clinical demand recovery
Aug 27 - Jinhai Medical Technology H1 revenue jumps on China strength
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Medlive Technology
See all newsMedlive Technology half-year revenue rises 1% on customer base expansion
Brief: Medlive Technology Posts Full-Year Revenue Of RMB 642.2 Million
Brief: Medlive Technology Logs H1 Adjusted Net Income RMB166.7 Mln
Brief: Medlive Technology Posts FY Adjusted Net Income Of RMB323.6 Million
Brief: Medlive Technology Declares Interim Dividend Of RMB12.05 Cents Per Ordinary Share